Next Generation Sequencing

NGS profiling improves patient outcomes while also lowering treatment costs and time to diagnosis for cancer patients.

Other relevant content

What ways are we innovating CAR-T, ADCs, Immunotherapies, and mRNAs as they wind their way through the pipeline and beyond? How…

Next Generation Sequencing

Live Biotherapeutics at a Crossroad Novotech White Paper Outlines Opportunities and Early-Stage…

Novotech Showcased in Global Biotech Series for Innovation in Hepatitis B Research

Novotech Wins Citeline CRO Partnership of the Year Award for Strategic Collaboration with Tune…

Obesity: Global Clinical Trial Landscape (2025)

Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)

Mitigating Risk with Ex-US Clinical Trials

Navigating the Early Oncology Landscape: Market Trends and Insights

Indian Biotech Phase IIB

What makes in-vivo CAR therapies the next frontier in cell therapy?

2025 Global Report for In-Vivo CAR Cell Therapy

Covid-19 Notice important updates

Find content relevant to:

Australia and New Zealand Site Solutions Summit 2025

BIO Asia–Taiwan 2025

Medical and Regulatory Consulting

Patient Recruitment and Site Selection

Early Phase Trials in Australia

Clinical Operations and Project Management

Site Management Organization (SMO)

Biometrics CRO and Data Management

Virtual Clinical Trials

Real world data

Laboratory Services

FLEX

Oncology CRO services

Pharmacometric Services

Drug Development Consulting

GMO Solutions

Liver Disease CRO services

Infectious diseases and Vaccines CRO services

Orphan and rare disease CRO services

Clinical and Regulatory Strategy

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all...

Novotech is a global full-service Contract Research Organization (CRO) providing clinical development services across all clinical trial phases and therapeutic...

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and...

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their...

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

Other relevant content

Triple-Negative Breast Cancer: Global Clinical Trial Landscape (2024)

Indian Biotech Phase IIB

Oncolytic Virus Therapy Clinical Trials Global Landscape Whitepaper 2024

Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from…

FAQs on the Oncolytic Virus Therapy: Insights into Clinical Trial Landscape and Industry Trends

Overview of Triple-Negative Breast Cancer: Global Clinical Trial Landscape

Novotech Releases Comprehensive Report on Oncolytic Virus Therapy

Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials

Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology…

Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung…

ASCO Annual Meeting (In Person)

Oncology CRO services